SEC FORM 4
$214,436.00
UNITED THERAPEUTICS Corp (UTHR)
Sale of 400 shares at $536.09 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Oct 9, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001106578-26-000161 · filed 2026-10-13 · View filing →